Survival in cancer of unknown primary site: population-based analysis by site and histology

被引:112
作者
Hemminki, K. [1 ,2 ]
Bevier, M. [1 ]
Hemminki, A. [3 ,4 ,5 ,6 ]
Sundquist, J. [2 ,7 ]
机构
[1] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany
[2] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden
[3] Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland
[4] Univ Helsinki, Transplantat Lab, Helsinki, Finland
[5] Univ Helsinki, Haartman Inst, Helsinki, Finland
[6] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland
[7] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA
关键词
histology; metastasis; prognosis; survival; PROGNOSTIC-FACTORS; PRIMARY-CARCINOMA; METASTASES; MANAGEMENT; DIAGNOSIS; TUMORS;
D O I
10.1093/annonc/mdr536
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer of unknown primary (CUP) is diagnosed at a metastatic stage, conferring an unfavorable prognosis. The natural history of the disease is poorly understood, which complicates diagnosis, treatment and follow-up. Population-based survival data are lacking regarding location and histology of metastases. From the Swedish Cancer Registry, 18 911 CUP patients were identified between years 1987 and 2008. Survival was analyzed by Kaplan-Meier survival curves and Cox regression. Adenocarcinoma accounted for 70% of all extranodal cases with a 12-month survival of 17% and the median survival of 3 months. Adenocarcinoma was also the most common histology (33.4%) when metastases were limited to lymph nodes, with a 12-month survival of 41% and median survival of 8 months. For extranodal metastases, the extremes in survival were small intestinal cancer with poor prognosis and mediastinal cancer with favorable prognosis. For nodal metastases, patients affected in the head and neck, axillary and inguinal regions had the best prognosis and those with abdominal and intrapelvic metastases the worst prognosis. The present data underline the importance of histology and location of metastasis in assisting clinical decision making: hazard ratios differed by a factor of five among extranodal and nodal metastases.
引用
收藏
页码:1854 / 1863
页数:10
相关论文
共 29 条
[1]   ANALYSIS OF A DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED TUMORS OF UNKNOWN ORIGIN [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
LENZI, R ;
HESS, KR ;
RABER, MN .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2094-2103
[2]   UNKNOWN PRIMARY-CARCINOMA - NATURAL-HISTORY AND PROGNOSTIC FACTORS IN 657 CONSECUTIVE PATIENTS [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
HESS, KR ;
RABER, MN ;
LENZI, R ;
FROST, P .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1272-1280
[3]  
ALTMAN E, 1986, CANCER-AM CANCER SOC, V57, P120, DOI 10.1002/1097-0142(19860101)57:1<120::AID-CNCR2820570124>3.0.CO
[4]  
2-M
[5]   Brain metastases in patients with cancer of unknown primary [J].
Bartelt, S ;
Lutterbach, J .
JOURNAL OF NEURO-ONCOLOGY, 2003, 64 (03) :249-253
[6]  
Centre for Epidemiology, 2007, CANC INC SWED 2005 S
[7]   Cancer metastasis networks and the prediction of progression patterns [J].
Chen, L. L. ;
Blumm, N. ;
Christakis, N. A. ;
Barabasi, A-L ;
Deisboeck, T. S. .
BRITISH JOURNAL OF CANCER, 2009, 101 (05) :749-758
[8]   Prognostic Factors in Unknown Primary Cancer [J].
Culine, Stephane .
SEMINARS IN ONCOLOGY, 2009, 36 (01) :60-64
[9]   Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity [J].
Curiel, TJ ;
Wei, S ;
Dong, HD ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Krzysiek, R ;
Knutson, KL ;
Daniel, B ;
Zimmermann, MC ;
David, O ;
Burow, M ;
Gordon, A ;
Dhurandhar, N ;
Myers, L ;
Berggren, R ;
Hemminki, A ;
Alvarez, RD ;
Emilie, D ;
Curiel, DT ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2003, 9 (05) :562-567
[10]   Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Fizazi, K. ;
Greco, F. A. ;
Pavlidis, N. ;
Pentheroudakis, G. .
ANNALS OF ONCOLOGY, 2011, 22 :vi64-vi68